招聘
Sarepta

Sarepta
Genetic medicine company
Gene Therapy
Drug Development
Clinical Research
Molecular Biology
Biostatistics
开放职位
0个职位
目前没有开放的职位
产品与服务
EL
ELEVIDYS
Gene Therapy

ELEVIDYS
Gene Therapy

EXONDYS 51
Antisense Oligonucleotide
EX
EXONDYS 51
RNA-targeted Therapy

VYONDYS 53
Antisense Oligonucleotide
VY
VYONDYS 53
RNA-targeted Therapy

AMONDYS 45
Antisense Oligonucleotide
AM
AMONDYS 45
RNA-targeted Therapy

VILTEPSO
Antisense Oligonucleotide
SR
SRP-9001
Gene Therapy
CA
CASIMERSEN
RNA-targeted Therapy

SRP-9001
Gene Therapy

Limb-girdle muscular dystrophy programs
Gene Therapy
LI
Limb-girdle Muscular Dystrophy Programs
Gene Therapy

RNA-targeted therapeutics platform
Platform Technology
CH
Charcot-Marie-Tooth Disease Programs
Neuromuscular Therapy
相似公司

Quest Diagnostics
Public
Clinical laboratory company
Secaucus, New Jersey, United States
10,001+
Valuation $10.8B

Bio-Rad
Public
Global leader in life science research and clinical diagnostics
Hercules, California, United States
5,001-10,000
Valuation $3.2B

HCA Healthcare
Public
Leading company in the healthcare industry
Nashville, Tennessee, United States
10,001+
Valuation $75B
96 open jobs

Freenome
Series C
AI genomics company for cancer detection
South San Francisco, CA
201-500
Valuation $2.3B
33 open jobs

Caribou Biosciences
Series C
CRISPR genome editing company
Berkeley, CA
201-500
4 open jobs

Editas Medicine
Public
Genome editing company
Cambridge, Massachusetts, United States
201-500
Valuation $1.2B
新闻动态
All
X
News
HN
YouTube
H.C. Wainwright reiterates Sarepta stock Sell rating at $5 target - Investing.com
Investing.com
News
·
4天前
Will Roche’s New Global Elevidys Phase 3 Trial Shift Sarepta Therapeutics' (SRPT) Gene Therapy Narrative? - simplywall.st
simplywall.st
News
·
4天前
Sarepta/ Roche Duchenne therapy to face new late-stage trial targeting EU nod - Seeking Alpha
Seeking Alpha
News
·
5天前
Roche to start new Elevidys study following setback in Europe - BioPharma Dive
BioPharma Dive
News
·
5天前
Roche to launch another Elevidys study after EU rejection of Duchenne gene therapy - Fierce Pharma
Fierce Pharma
News
·
5天前
更多 (剩余15条)
总浏览量
0
申请点击数
0
模拟申请者数
0
收藏
0
评价
3.8
48条评价
工作生活平衡
3.5
薪酬
3.9
企业文化
4.0
职业发展
4.0
管理层
3.6
76%
推荐给朋友
优点
Good work-life balance and flexible environment
Supportive team and management
Competitive compensation and benefits
缺点
Some organizational bureaucracy
Room for improvement in processes
Work-life balance varies by team
薪资范围
47个数据点
Director
Mid/L4
Senior/L5
Director
3份报告
$243,750
年薪总额
基本工资
$187,500
股票
-
$240,500
$247,000
面试经验
5次面试
难度
2.2
/ 5
时长
2-5w
录用率
40%
体验
正面 60%
中性 20%
负面 20%
面试流程
1
Application Review
2
HR/Recruiter Screen
3
Technical/Phone Screen
4
Hiring Manager Interview
5
Panel/Onsite Interviews
6
Offer
联系方式与地址